Trevor Brasel PhD

Trevor L. Brasel, PhD, M(ASCP)CM

Study Director, Institutional Office of Regulated Nonclinical Studies
Assistant Professor, Department of Microbiology & Immunology

Phone: (409) 266-6907
Mail Route: 0610
Office: Galveston National Laboratory (GNL) 5.200U
Email: trbrasel@utmb.edu

Education
M(ASCP)CM
American Society for Clinical Pathology
2018
Houston, TX
Categorical Certification, Clinical Microbiology
University of Texas Medical Branch
2018
Galveston, TX
Post-doctoral Fellowship
Lovelace Respiratory Research Institute and
The Research Centre for Toxicology and Hygienic Regulation of Biopreparations
2005
Albuquerque, NM and Serpukhov, Russia
PhD, Medical Microbiology
Texas Tech University Health Sciences Center
2004
Lubbock, TX
BS, Microbiology
Texas Tech University
2000
Lubbock, TX
Research Interests
Medical countermeasure development and testing, animal model development, assay qualification/validation, regulated studies, GLP
Current Research
Dr. Brasel's research focuses on the strategic planning and execution of preclinical studies that evaluate medical countermeasures (vaccines and therapeutics) toward licensure. His primary interests lie in the implementation of quality systems and regulatory processes in BSL-3 and BSL-4 laboratories to advance product development. Current projects include vaccine and therapeutic development and testing against filoviruses, including Ebola and Marburg viruses, and SARS-CoV-2, the causative agent of COVID-19. As a means to further advance the field of regulatory science in high biocontainment laboratories, Dr. Brasel is serving as co-Principal Investigator on a grant funded through the FDA entitled "Achieving Data Quality and Integrity in Maximum Containment Laboratories," now in its eighth year of funding (https://www.fda.gov/emergency-preparedness-and-response/mcmi-professional-development-activities/training-course-achieving-data-quality-and-integrity-maximum-containment-laboratories). Dr. Brasel's ultimate goal is FDA approval of high-profile medical countermeasures specific for biodefense-related and emerging diseases.
Publications
Search PubMed Database for Publications